4.3 Article

ENDOTRACHEAL INTUBATION AFTER ACUTE DRUG OVERDOSES: INCIDENCE, COMPLICATIONS, AND RISK FACTORS

Journal

JOURNAL OF EMERGENCY MEDICINE
Volume 52, Issue 1, Pages 59-65

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jemermed.2016.07.114

Keywords

overdose; intubation; risk factors

Funding

  1. National Institutes of Health/National Institute on Drug Abuse [DA026476]
  2. NIH/NIDA [DA037317]

Ask authors/readers for more resources

Background: Drug overdose is the leading cause of injury-related fatality in the United States, and respiratory failure remains a major source of morbidity and mortality. Objectives: We aimed to identify the incidence and risk factors for endotracheal intubation after acute drug overdose. Methods: This secondary data analysis was performed on a 5-year prospective cohort at two urban tertiary-care hospitals. The present study analyzed adult patients with suspected acute drug overdose to derive independent clinical predictors of endotracheal intubation. Results: We analyzed 2497 patients with acute drug overdose, of whom 87 (3.5%) underwent endotracheal intubation. Independent clinical risk factors for endotracheal intubation were: younger age (odds ratio [OR] 0.97, 95% confidence interval [CI] 0.96-0.98), and history of obstructive lung disease (OR 6.6, 95% CI 3.5-12.3); however, heart failure had no association. Patients with obstructive lung disease had significantly more hypercapnia (mean difference 6.8 mm Hg, 95% CI 2.3-11.3) and a higher degree of acidemia (mean pH difference 0.04, 95% CI 0.01-0.07) than patients without obstructive lung disease. Lack of rapid sequence sedative/paralytic was associated with in-hospital fatality. Early complications of endotracheal intubation itself included desaturation (3.4%) and bradycardia (1%). Conclusions: Endotracheal intubation was infrequently performed on patients with acute drug overdose, and complications were rare when performed. Risk factors associated with endotracheal intubation included younger age and prior obstructive lung disease. (C) 2016 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available